Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "DEAD box polypeptide 25 pseudogene" refers to a non-protein-coding pseudogene related to the DEAD-box helicase 25 (DDX25) gene. Pseudogenes are remnants of genes that have lost their protein-coding ability or are otherwise nonfunctional, often due to mutations. They may sometimes have regulatory functions at the RNA level, including potential roles in generating small RNAs, but they do not produce a functional protein product and are generally not considered valid therapeutic targets[4]. Clarification and Context: - The Ensembl identifier ENSG00000251682 specifically designates a pseudogene, not the active, protein-coding DDX25 gene (which is ENSG00000109832)[1]. - Pseudogenes are conventionally not considered therapeutic targets because they do not encode functional proteins; thus, there are no known disease associations, molecular functions, direct drug interactions, or established roles as biomarkers for this pseudogene[1][4]. - While the DDX25 protein itself is an RNA helicase with recognized biological functions, its pseudogene ("DEAD box polypeptide 25 pseudogene") does not share these properties or clinical relevance[1][3]. - Specifying the pseudogene as the target appears to be either a mistake, a misannotation, or a non-canonical approach for therapeutic targeting. Therefore, this entry should be flagged as is_incorrect: true, since it is not a standard or meaningful drug discovery or therapeutic entity. Summary Statement: The queried target, "DEAD box polypeptide 25 pseudogene" (ENSG00000251682), is a pseudogene and is not a protein-coding gene, receptor, enzyme, or other typical therapeutic target. It should not be used where active targets are required in biomedical applications or drug discovery[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DEAD box polypeptide 25 pseudogene.